Clinical Trials Browser

Phase 2 × Neuroectodermal Tumors, Primitive × Temozolomide × Clear all

NCT06861244 2026-01-07

PNOC031

Phase 2 Recruiting

Neuroectodermal Tumors, Primitive, Pyloric Stenosis, Hypertrophic

NCT02358356 2022-07-05

CONTROL NETS

Phase 2 Completed

Neuroectodermal Tumors, Primitive

NCT01217437 2021-07-23

Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors

Phase 2 Completed

108 enrolled 14 charts

Medulloblastoma, Pinealoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Neuroectodermal Tumors, Primitive